Serum C‐reactive protein levels predict survival in hepatocellular carcinomaSakae Nagaoka, Michio Sata, Takafumi Yoshida et al.|Liver International|2007Cited by 102
Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapyTakashi Niizeki, Michio Sata, Junichi Kurogi et al.|Journal of Gastroenterology|2012Cited by 59
Prophylactic Lamivudine Administration Prevents Exacerbation of Liver Damage in HBe Antigen Positive Patients with Hepatocellular Carcinoma Undergoing Transhepatic Arterial Infusion ChemotherapyHiroaki Nagamatsu, Michio Sata, Satoshi Itano et al.|The American Journal of Gastroenterology|2004Cited by 55
Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findingsSakae Nagaoka, Michio Sata, Satoshi Itano et al.|Liver International|2006Cited by 45
Efficacy, Safety, and Survival Factors for Sorafenib Treatment in Japanese Patients with Advanced Hepatocellular CarcinomaMasahito Nakano, Masatoshi Tanaka, Ryoko Kuromatsu et al.|Oncology|2012Cited by 34